Dr. Lambros Zellos
Dr. Lambros Zellos M.D.
Dr. Lambros Zellos is an Associate Surgeon and Clinical Co-Director of the International Mesothelioma Program and a thoracic surgeon at the Brigham and Women’s Hospital located in Boston, Massachusetts.
75 Francis St Boston, MA 02115
Dr. Lambros Zellos is an Associate Surgeon and Clinical Co-Director of the International Mesothelioma Program and a thoracic surgeon at the Brigham and Women’s Hospital located in Boston, Massachusetts. Dr. Zellos also holds an academic appointment at Harvard Medical School where he is an instructor in surgery. Additionally, Dr. Zellos is associated with three distinguished professional organizations, the American Medical Association, International Society for Heart and Lung Transplantation, and the Candidate Group American College of Surgeons.
Education and Training
Dr. Zellos completed his undergraduate work in biology at the University of Maryland College Park, after which he attended the Georgetown University School of medicine, obtaining his medical doctorate in May 1994. He went on to receive his Masters in Public Health from Harvard’s School of Public health. While in school, Dr. Zellos was a member of several honor societies including Phi Sigma Biological Honor Society and Phi Kappa Phi National Honor Society to name a few. His numerous residencies and fellowships span the course of ten years and were completed at Georgetown University Medical Center, Harvard medical School, and Brigham and Women’s Hospital.
Since graduating from medical school, Dr. Zellos has attained various licensure and certifications that qualify him for his position, these include:
2005 Certificate American Board of Thoracic Surgery
2004 Certificate American Board of Surgery
1999 District of Columbia Medical License
1996 Commonwealth of Massachusetts Medical License
1995 USMLE III
1994 USMLE II
1992 USMLE I
Among his qualifications academically and professionally, Dr. Zellos was awarded the Marguerite George Resident Award for Excellence in vascular Surgery in 2000 and the John J. Collins Cardiothoracic Surgeon Scholar Award in 2004.
Research and Publications
From 1997 to 2000, Dr. Zellos served on the Medical Records Committee which is a part of the Georgetown University Medical Center. He has published numerous abstracts, journal articles, and book chapters, as well as participated in presentations offered at both national and international symposiums and conferences. The treatment of mesothelioma, specifically multimodal approaches to treatment and aggressive surgical procedures, are often the topic of Dr. Zellos’ research, a sample of which is provided below:
Sugarbaker D, Richards WG, Zellos LS, et al. Feasibility of pleurectomy and intraoperative bicavitary hyperthermic cisplatin lavage for mesothelioma phase I-II study. Proc Am Soc Clin Oncol. 2003;22620. Abstract 2494.
Joel Wright PhD, Olga Tretyakov MD, Emil Frei III MD, William Richards PhD, Lambros Zellos MD, Lea Capalbo BS, Elizabeth Olread MPH, Raphael Bueno MD, Michael Jaklitsch MD, Jean Lukanich MD, Scott Swanson MD, David Sugarbaker MD, Pharmacological Phase I Study of Heated, Intraoperative, Intrapleural and Intraperitoneal Cisplatin During Extrapleural Pneumonectomy for Pleural Mesothelioma. ASCO 2001
Zellos L., Sugarbaker D.J., Wound recurrence in pleural mesothelioma American Thoracic Society International Conference, Atlanta, Georgia, 2002. Am J Respir Crit Care Med 2002
David J. Sugarbaker, M.D. Michael T. Jaklitsch, M.D. Raphael Bueno, M.D. William Richard, Ph.D., Jeanne Lukanich, M.D., Steven J. Mentzer, M.D. Yolonda Colson, M.D. Ph.D., Phillip Linden, M.D., Michael Chang, M.D., Leah Capalbo, Elizabeth Oldread,Siyamek Neragi-Miandoab, M.D. Ph.D., Scott J. Swanson, M.D.,* Lambros Zellos, M.D. Prevention, Early Detection and Management of Complications Following 328 Consecutive Extrapleural Pneumonectomies J Thorac Cardiovasc Surg. 2004 Jul;128(1):138-46.
Zellos L, Sugarbaker DJ. Multimodality treatment of diffuse malignant pleural mesothelioma. Semin Oncol 2002 Feb; 29(1): 41-50
Zellos L., Sugarbaker D.J. Surgical Management of Mesothelioma Current Oncology Curr Oncol Rep. 2002 Jul; 4(4): 354-60.
Zellos L., Sugarbaker D.J. Diffuse Malignant Mesothelioma of the Pleura and Its Treatment Oncology (Huntingt). 2002 Jul; 16(7): 907-13; discussion 916-7, 919-20, 925.
Lambros Zellos MD MPH, David Christiani MD Epidemiology, Biologic Behavior and Natural History of Mesothelioma Thorac Surg Clin. 2004 Nov;14(4):469-77, viii.
Lambros Zellos, David J. Sugarbaker Extrapleural pneumonectomy Current Therapy Thoracic and Cardiovascular Surgery [Editors Steven C. Yang & Duke E. Cameron] Publisher: Mosby; (April 9, 2004)
Lambros Zellos, David J. Sugarbaker Malignant Pleural Mesothelioma Pleural Disease (Lung Biology in Health and Disease); Editor: Demosthenes Bouros; Publisher: Marcel Dekker; February 2004
David J. Sugarbaker, Lambros Zellos, Ben Davis Diseases of the Chest wall, Pleura, Mediastinum, & Trachea Surgery: Scientific Principles & Practice 3rd Edition; Editor: L Greenfield; Publisher: Lippincott Williams & Wilkins Publishers; 3rd edition (December 15, 2001)
Zellos L., Complications following Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Presented at IASLC 2004 Mesothelioma Workshop Ermitagen Switzerland
Zellos L.* Intracavitary Chemotherapy After Exrapleural Pneumonectomy For the Treatment of Diffuse Malignant Pleural Mesothelioma Presented at Brigham & Women’s Hospital, Division of Thoracic Surgery Conference